Valuation GlaxoSmithKline Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. Other stock markets 06:00:55 2026-07-03 am EDT			5-day change	1st Jan Change
2,392.75 ^INR	-0.96%		+1.44%	-3.16%

May. 29	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026	CI
May. 13	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit	MT

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	281,714	224,319	329,173	487,432	386,822	405,346	-
Change	-	-20.37%	46.74%	48.08%	-20.64%	4.79%	-
Enterprise Value (EV)	256,351	207,663	329,173	487,432	386,822	405,346	405,346
Change	-	-18.99%	58.51%	48.08%	-20.64%	4.79%	0%
P/E	16.6x	36.7x	55.8x	52.5x	37.3x	35.6x	31.5x
PBR	10.6x	12.9x	18.5x	25x	17.1x	15.2x	12.9x
PEG	-	-0.6x	-16.49x	0.9x	3.2x	3.5x	2.4x
Capitalization / Revenue	8.59x	6.9x	9.53x	13x	10.1x	9.67x	8.73x
EV / Revenue	0x	0x	0x	0x	0x	9.67x	8.73x
EV / EBITDA	0x	0x	0x	0x	0x	27.6x	24.3x
EV / EBIT	0x	0x	0x	0x	0x	29.5x	25.8x
EV / FCF	0x	0x	0x	0x	0x	35x	31.5x
FCF Yield	2.75%	1.96%	1.67%	2.6%	2.19%	2.86%	3.17%
Dividend per Share ²	30	32	32	42	57	29.5	29.5
Rate of return	1.8%	2.42%	1.65%	1.46%	2.5%	1.23%	1.23%
EPS ²	100	36.05	34.83	54.76	61.15	67.3	75.97
Distribution rate	30%	88.8%	91.9%	76.7%	93.2%	43.8%	38.8%
Net sales ¹	32,780	32,517	34,537	37,492	38,217	41,939	46,453
EBITDA ¹	8,273	8,043	9,087	11,774	13,092	14,683	16,675
EBIT ¹	7,592	7,385	8,390	11,106	12,428	13,760	15,728
Net income ¹	16,947	6,107	5,900	9,276	10,360	11,402	12,873
Net Debt	-25,363	-16,656	-	-	-	-	-
Reference price ²	1,662.95	1,324.15	1,943.10	2,877.30	2,283.40	2,392.75	2,392.75
Nbr of stocks (in thousands)	169,406	169,406	169,406	169,406	169,406	169,406	-
Announcement Date	5/16/22	5/17/23	5/17/24	5/13/25	5/13/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	35.55x	-	-	1.23%	4.26B
ELI LILLY AND COMPANY	35.49x	12.89x	26.26x	0.56%	1,082B
JOHNSON & JOHNSON	28.11x	6.46x	17.57x	2.03%	633B
ABBVIE INC.	32.2x	7.69x	15.73x	2.65%	461B
ROCHE HOLDING AG	18.15x	4.51x	11.08x	2.94%	338B
ASTRAZENECA PLC	24.06x	5.03x	14.1x	1.73%	299B
NOVARTIS AG	22.19x	5.69x	13.74x	2.76%	291B
NOVO NORDISK A/S	14.43x	5.37x	11.03x	3.47%	222B
AMGEN INC.	24.39x	6.45x	11.36x	2.7%	202B
GILEAD SCIENCES, INC.	-46.87x	5.66x	31.47x	2.47%	163B
Average	18.77x	6.64x	16.92x	2.25%	369.67B
Weighted average by Cap.	24.75x	8.04x	18.59x	1.94%